• OPEN AN ACCOUNT
Indian Indices
Nifty
25,453.40 -88.40
(-0.35%)
Sensex
83,409.69 -287.60
( -0.34%)
Bank Nifty
56,999.20 -460.25
( -0.80%)
Nifty IT
38,879.10 45.95
( 0.12%)
Global Indices
Nasdaq
44,498.76 -17.19
(-0.04%)
Dow Jones
6,247.07 28.06
(0.45%)
Hang Seng
39,758.37 -227.96
(-0.57%)
Nikkei 225
8,774.69 -10.64
(-0.12%)
Forex
USD-INR
85.62 0.21
(0.25%)
EUR-INR
100.54 0.47
(0.47%)
GBP-INR
117.42 0.25
(0.22%)
JPY-INR
0.59 0.00
(0.57%)

EQUITY - MARKET SCREENER

BSE Bharat 22 Index
Industry :  Stock Exchanges
BSE Code
ISIN Demat
Book Value()
1016
N.A
0
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
13.7
4723636.32
EPS(TTM)
Face Value()
Div & Yield %
0
100
2.8
 

Shukra Pharmaceuticals standalone net profit rises 35.09% in the March 2025 quarter
May 30,2025
Net profit of Shukra Pharmaceuticals rose 35.09% to Rs 5.39 crore in the quarter ended March 2025 as against Rs 3.99 crore during the previous quarter ended March 2024. Sales rose 21.97% to Rs 13.27 crore in the quarter ended March 2025 as against Rs 10.88 crore during the previous quarter ended March 2024.

For the full year,net profit declined 48.33% to Rs 9.58 crore in the year ended March 2025 as against Rs 18.54 crore during the previous year ended March 2024. Sales declined 56.30% to Rs 32.59 crore in the year ended March 2025 as against Rs 74.57 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales13.2710.88 22 32.5974.57 -56
OPM %55.0940.81 -39.0326.02 -
PBDT8.515.75 48 16.3421.93 -25
PBT7.575.23 45 13.3419.88 -33
NP5.393.99 35 9.5818.54 -48